Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 202

1.

A multicenter comparison of established and emerging cardiac biomarkers for the diagnostic evaluation of chest pain in the emergency department.

Bhardwaj A, Truong QA, Peacock WF, Yeo KT, Storrow A, Thomas S, Curtis KM, Foote RS, Lee HK, Miller KF, Januzzi JL Jr.

Am Heart J. 2011 Aug;162(2):276-282.e1. doi: 10.1016/j.ahj.2011.05.022.

PMID:
21835288
2.

Sensitive troponin assays and N-terminal pro-B-type natriuretic peptide in acute coronary syndrome: prediction of significant coronary lesions and long-term prognosis.

Gravning J, Smedsrud MK, Omland T, Eek C, Skulstad H, Aaberge L, Bendz B, Kjekshus J, Mørkrid L, Edvardsen T.

Am Heart J. 2013 May;165(5):716-24. doi: 10.1016/j.ahj.2013.02.008.

PMID:
23622908
3.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

4.

Prognostic value of a multimarker approach for patients presenting to hospital with acute chest pain.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.

Am J Cardiol. 2009 Jan 1;103(1):22-8. doi: 10.1016/j.amjcard.2008.08.026.

PMID:
19101224
6.

Investigation of a multimarker approach to the initial assessment of patients with acute chest pain.

McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B, Sharpe PC, Young IS, Adgey JA.

Adv Ther. 2009 May;26(5):531-4. doi: 10.1007/s12325-009-0032-7.

PMID:
19475367
7.

A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.

Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB.

Clin Chim Acta. 2007 Feb;376(1-2):168-73.

PMID:
17011538
8.

Copeptin does not add diagnostic information to high-sensitivity troponin T in low- to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study.

Karakas M, Januzzi JL Jr, Meyer J, Lee H, Schlett CL, Truong QA, Rottbauer W, Bamberg F, Dasdemir S, Hoffmann U, Koenig W.

Clin Chem. 2011 Aug;57(8):1137-45. doi: 10.1373/clinchem.2010.160192.

9.

Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP.

Clin Chem. 2010 Nov;56(11):1718-24. doi: 10.1373/clinchem.2009.141341.

10.

Absolute and relative kinetic changes of high-sensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome.

Mueller M, Biener M, Vafaie M, Doerr S, Keller T, Blankenberg S, Katus HA, Giannitsis E.

Clin Chem. 2012 Jan;58(1):209-18. doi: 10.1373/clinchem.2011.171827.

11.

Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.

de Antonio M, Lupon J, Galan A, Vila J, Urrutia A, Bayes-Genis A.

Am Heart J. 2012 May;163(5):821-8. doi: 10.1016/j.ahj.2012.03.004.

PMID:
22607860
12.

Heart-type fatty acid binding protein (H-FABP) in patients in an emergency department setting, suspected of acute coronary syndrome: optimal cut-off point, diagnostic value and future opportunities in primary care.

Willemsen RT, van Severen E, Vandervoort PM, Grieten L, Buntinx F, Glatz JF, Dinant GJ.

Eur J Gen Pract. 2015;21(3):156-63. doi: 10.3109/13814788.2015.1013934. Erratum in: Eur J Gen Pract. 2015;21(3):x.

PMID:
25751665
13.

Short-term serial sampling of natriuretic peptides in patients presenting with chest pain.

Kwan G, Isakson SR, Beede J, Clopton P, Maisel AS, Fitzgerald RL.

J Am Coll Cardiol. 2007 Mar 20;49(11):1186-92.

14.

N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.

Yamashita T, Seino Y, Ogawa A, Ogata K, Fukushima M, Tanaka K, Mizuno K.

J Cardiol. 2010 May;55(3):377-83. doi: 10.1016/j.jjcc.2010.01.008.

15.

No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome.

Poldervaart JM, Röttger E, Dekker MS, Zuithoff NP, Verheggen PW, de Vrey EA, Wildbergh TX, van 't Hof AW, Mosterd A, Hoes AW.

PLoS One. 2015 Jul 15;10(7):e0132000. doi: 10.1371/journal.pone.0132000.

16.

N-terminal pro-brain natriuretic peptide and high-sensitivity troponin in the evaluation of acute chest pain of uncertain etiology. A PITAGORAS substudy.

Sanchis J, Bardají A, Bosch X, Loma-Osorio P, Marín F, Sánchez PL, Calvo F, Avanzas P, Hernández C, Serrano S, Carratalá A, Barrabés JA.

Rev Esp Cardiol (Engl Ed). 2013 Jul;66(7):532-8. doi: 10.1016/j.rec.2012.11.004.

PMID:
24776201
19.

Incremental prognostic value of biomarkers beyond the GRACE (Global Registry of Acute Coronary Events) score and high-sensitivity cardiac troponin T in non-ST-elevation acute coronary syndrome.

Widera C, Pencina MJ, Bobadilla M, Reimann I, Guba-Quint A, Marquardt I, Bethmann K, Korf-Klingebiel M, Kempf T, Lichtinghagen R, Katus HA, Giannitsis E, Wollert KC.

Clin Chem. 2013 Oct;59(10):1497-505. doi: 10.1373/clinchem.2013.206185.

20.

N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.

Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.

Am J Med. 2011 Aug;124(8):731-9. doi: 10.1016/j.amjmed.2011.02.035.

PMID:
21787902
Items per page

Supplemental Content

Support Center